PARSHALL B LYNNE
SEC CIK 1073385 · EDGAR
BoughtSold
Most active insiders at CYTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| 2 | Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| 3 | Lee Sung | EVP, CFO | — | $5.70M |
| 4 | Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| 5 | Kaye Edward M. MD | Dir | — | $3.21M |
| 6 | HENDERSON JOHN T | Dir | — | $2.08M |
| 7 | WIERENGA WENDELL | Dir | — | $1.88M |
| 8 | PARSHALL B LYNNE | Dir | — | $1.36M |
| 9 | Landry Robert E | Dir | — | $146.8K |
| 10 | Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 46
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-01 16:51 | 2026-09-01 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale | $71.48 | -5,000 | 10.8K | -32% | -$357.4K |
| T | 2026-06-01 18:49 | 2026-06-01 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale | $74.08 | -5,000 | 15.8K | -24% | -$370.4K |
| D | 2026-05-27 19:10 | 2026-05-27 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +2,851 | 20.8K | +16% | $0 |
| MT | 2026-04-17 19:19 | 2026-04-15 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | S - Sale | $76.27 | -5,000 | 51.3K | -9% | -$381.4K |
| 2026-03-02 | 2026-03-02 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale | $61.21 | -5,000 | 17.9K | -22% | -$306.1K | |
| 2026-02-13 | 2026-02-11 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | S - Sale | $82.72 | -5,000 | 56.3K | -8% | -$413.6K | |
| 2025-11-19 | 2025-11-19 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale | $64.73 | -5,000 | 22.9K | -18% | -$323.6K | |
| 2025-10-16 | 2025-10-15 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | S - Sale | $71.74 | -5,000 | 61.3K | -8% | -$358.7K | |
| M | 2025-09-04 | 2025-09-02 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | S - Sale | $50.91 | -20.0K | 75.6K | -21% | -$1.02M |
| M | 2025-08-08 | 2025-08-06 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | S - Sale | $41.93 | -5,000 | 86.7K | -5% | -$209.7K |
| D | 2025-07-17 | 2025-07-15 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +4,079 | 91.3K | +5% | $0 |
| D | 2025-05-15 | 2025-05-14 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +7,333 | 27.9K | +36% | $0 |
| D | 2024-09-09 | 2024-09-09 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $54.92 | -5,000 | 20.6K | -20% | -$274.6K |
| D | 2024-09-09 | 2024-09-09 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-08-26 | 2024-08-26 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $57.26 | -5,000 | 20.6K | -20% | -$286.3K |
| D | 2024-08-26 | 2024-08-26 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-08-12 | 2024-08-12 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-08-12 | 2024-08-12 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $55.20 | -5,000 | 20.6K | -20% | -$276.0K |
| D | 2024-07-31 | 2024-07-29 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-07-31 | 2024-07-29 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $59.84 | -5,000 | 20.6K | -20% | -$299.2K |
| D | 2024-07-17 | 2024-07-15 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +4,677 | 87.3K | +6% | $0 |
| D | 2024-07-16 | 2024-07-15 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $55.82 | -5,000 | 20.6K | -20% | -$279.1K |
| D | 2024-07-16 | 2024-07-15 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 25.6K | +24% | +$53.4K |
| D | 2024-07-01 | 2024-07-01 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 25.6K | +24% | +$53.4K |
| D | 2024-07-01 | 2024-07-01 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $54.22 | -5,000 | 20.6K | -20% | -$271.1K |
| D | 2024-06-17 | 2024-06-17 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 25.6K | +24% | +$53.4K |
| D | 2024-06-17 | 2024-06-17 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $52.55 | -5,000 | 20.6K | -20% | -$262.8K |
| D | 2024-06-04 | 2024-06-03 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 20.6K | +32% | +$53.4K |
| D | 2024-06-04 | 2024-06-03 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $48.64 | -5,000 | 15.6K | -24% | -$243.2K |
| D | 2024-05-16 | 2024-05-15 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +5,600 | 20.6K | +37% | $0 |
| DM | 2023-12-28 | 2023-12-26+ | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $50.48 | -117.6K | 82.6K | -59% | -$5.94M |
| DM | 2023-12-28 | 2023-12-26+ | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | M - OptEx | $47.34 | +117.6K | 125.1K | +1,574% | +$5.57M |
| 2023-09-28 | 2023-09-26 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | S - Sale | $45.13 | -10.0K | 82.6K | -11% | -$451.3K | |
| DM | 2023-07-19 | 2023-07-17 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +7,110 | 92.6K | +8% | $0 |
| D | 2023-05-18 | 2023-05-10 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +5,000 | 15.0K | +50% | $0 |
| D | 2022-09-01 | 2022-09-01 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $52.79 | -30.3K | 10.0K | -75% | -$1.60M |
| DM | 2022-09-01 | 2022-09-01 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $8.92 | +30.3K | 15.7K | New | +$270.2K |
| DM | 2022-07-19 | 2022-07-15 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +7,998 | 82.8K | +11% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +5,000 | 10.0K | +100% | $0 |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +5,754 | 79.1K | +8% | $0 |
| D | 2022-01-20 | 2022-01-18 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | F - Tax | $30.12 | -1,652 | 77.5K | -2% | -$49.8K |
| DM | 2021-11-05 | 2021-11-05 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $40.00 | -31.0K | 5,000 | -86% | -$1.24M |
| DM | 2021-11-05 | 2021-11-05 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $12.34 | +31.0K | 7,798 | New | +$382.4K |
| DM | 2021-10-20 | 2021-10-19 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | M - OptEx | $6.65 | +10.3K | 6,999 | New | +$68.7K |
| DM | 2021-10-20 | 2021-10-19 | CYTK | CYTOKINETICS INC | PARSHALL B LYNNE | Dir | S - Sale+OE | $35.73 | -10.3K | 5,000 | -67% | -$369.2K |
| DM | 2021-07-19 | 2021-07-15 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +8,000 | 73.4K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations